Bhasin S, Brito JP, Cunningham GR, Hayes FJ, Hodis HN, Matsumoto AM, et al. Testosterone therapy in men with hypogonadism: an endocrine society* clinical practice guideline. J Clin Endocrinol Metab. 2018;103:1715–44.
Yeap BB, Wu FCW. Clinical practice update on testosterone therapy for male hypogonadism: contrasting perspectives to optimize care. Clin Endocrinol. 2019;90:56–65.
Salonia A, Bettocchi C, Boeri L, Capogrosso P, Carvalho J, Cilesiz NC, et al. European Association of Urology guidelines on sexual and reproductive health-2021 update: male sexual dysfunction. Eur Urol. 2021;80:333–57.
Tajar A, Forti G, O’Neill TW, Lee DM, Silman AJ, Finn JD, et al. Characteristics of secondary, primary, and compensated hypogonadism in aging men: evidence from the European Male Ageing Study. J Clin Endocrinol Metab. 2010;95:1810–8.
Article CAS PubMed Google Scholar
Corona G, Goulis DG, Huhtaniemi I, Zitzmann M, Toppari J, Forti G, et al. European Academy of Andrology (EAA) guidelines* on investigation, treatment and monitoring of functional hypogonadism in males. Andrology. 2020;8:970–87.
Basaria S. Male hypogonadism. Lancet. 2014;383:1250–63.
Article CAS PubMed Google Scholar
Wallin JA. Bibliometric methods: pitfalls and possibilities. Basic Clin Pharm Toxicol. 2005;97:261–75.
van Eck NJ, Waltman L. Software survey: VOSviewer, a computer program for bibliometric mapping. Scientometrics. 2010;84:523–38.
Ellegaard O, Wallin JA. The bibliometric analysis of scholarly production: how great is the impact? Scientometrics. 2015;105:1809–31.
Article PubMed PubMed Central Google Scholar
Rondanelli M, Perna S, Peroni G, Guido D. A bibliometric study of scientific literature in scopus on botanicals for treatment of androgenetic alopecia. J Cosmet Dermatol. 2016;15:120–30.
Corona G, Vignozzi L, Sforza A, Mannucci E, Maggi M. Obesity and late-onset hypogonadism. Mol Cell Endocrinol. 2015;418:120–33.
Article CAS PubMed Google Scholar
Corona G, Rastrelli G, Monami M, Saad F, Luconi M, Lucchese M, et al. Body weight loss reverts obesity-associated hypogonadotropic hypogonadism: a systematic review and meta-analysis. Eur J Endocrinol. 2013;168:829–43.
Article CAS PubMed Google Scholar
Corona G, Rastrelli G, Monami M, Guay A, Buvat J, Sforza A, et al. Hypogonadism as a risk factor for cardiovascular mortality in men: a meta-analytic study. Eur J Endocrinol. 2011;165:687–701.
Article CAS PubMed Google Scholar
Chan YM, Broder-Fingert S, Wong KM, Seminara SB. Kisspeptin/Gpr54-independent gonadotrophin-releasing hormone activity in Kiss1 and Gpr54 mutant mice. J Neuroendocrinol. 2009;21:1015–23.
Article CAS PubMed PubMed Central Google Scholar
Lapatto R, Pallais JC, Zhang D, Chan Y-M, Mahan A, Cerrato F, et al. Kiss1(-/-) mice exhibit more variable hypogonadism than Gpr54(-/-) mice. Endocrinology. 2007;148:4927–36.
Article CAS PubMed Google Scholar
Berthon A, Settas N, Delaney A, Giannakou A, Demidowich A, Faucz FR, et al. Kisspeptin deficiency leads to abnormal adrenal glands and excess steroid hormone secretion. Hum Mol Genet. 2020;29:3443–50.
Article CAS PubMed PubMed Central Google Scholar
Seminara SB, Messager S, Chatzidaki EE, Thresher RR, Acierno JS, Shagoury JK, et al. The GPR54 gene as a regulator of puberty. N Engl J Med. 2003;349:1614–U8.
Article CAS PubMed Google Scholar
Wu FCW, Tajar A, Beynon JM, Pye SR, Silman AJ, Finn JD, et al. Identification of late-onset hypogonadism in middle-aged and elderly men. N Engl J Med. 2010;363:123–35.
Article CAS PubMed Google Scholar
Bhasin S, Cunningham GR, Hayes FJ, Matsumoto AM, Snyder PJ, Swerdloff RS, et al. Testosterone Therapy in Men with Androgen Deficiency Syndromes: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2010;95:2536–59.
Article CAS PubMed Google Scholar
Snyder P. Testosterone treatment of late-onset hypogonadism - benefits and risks. Rev Endocr Metab Disord. 2022;23:1151–7.
Snyder PJ, Bhasin S, Cunningham GR, Matsumoto AM, Stephens-Shields AJ, Cauley JA, et al. Lessons From the Testosterone Trials. Endocr Rev. 2018;39:369–86.
Article PubMed PubMed Central Google Scholar
Kondoh N, Kaizuka Y, Nagasawa S, Togo Y, Yamamoto S. Predictive factors for efficacy of testosterone replacement therapy for late-onset hypogonadism in Japanese men: a preliminary report. Asian J Androl. 2023;25:587–90.
Article PubMed PubMed Central Google Scholar
Aribarg A, Zhang GY, Cao J, Li GZ, Anderson RA, Swerdloff RS, et al. Contraceptive efficacy of testosterone-induced azoospermia and oligozoospermia in normal men. Fertil Steril. 1996;65:821–9.
Shah R, Patil V, Sarathi V, Lila AR, Zacharin M, Krishnappa B, et al. Prior testosterone replacement therapy may impact spermatogenic response to combined gonadotropin therapy in severe congenital hypogonadotropic hypogonadism. Pituitary. 2021;24:326–33.
Article CAS PubMed Google Scholar
Rastrelli G, Filippi S, Sforza A, Maggi M, Corona G. Metabolic Syndrome in Male Hypogonadism. Front Horm Res. 2018;49:131–55.
Article CAS PubMed Google Scholar
Garcia-Cruz E, Piqueras M, Huguet J, Perez-Marquez M, Gosalbez D, Peri L, et al. Hypertension, dyslipidemia and overweight are related to lower testosterone levels in a cohort of men undergoing prostate biopsy. Int J Impot Res. 2012;24:110–3.
Article CAS PubMed Google Scholar
Dimopoulou C, Goulis DG, Corona G, Maggi M. The complex association between metabolic syndrome and male hypogonadism. Metabolism. 2018;86:61–8.
Article CAS PubMed Google Scholar
Taskin HE, Al M. Testosterone Changes in Men With Obesity and Type 2 Diabetes 6 Months After Sleeve Gastrectomy With Transit Bipartition. Surg Laparosc Endosc Percutan Tech. 2022;32:188–96.
Dhindsa S, Ghanim H, Jenkins T, Inge TH, Harmon CM, Ghoshal A, et al. High prevalence of subnormal testosterone in obese adolescent males: reversal with bariatric surgery. Eur J Endocrinol. 2022;186:319–27.
Article CAS PubMed Google Scholar
Genchi VA, Rossi E, Lauriola C, D’Oria R, Palma G, Borrelli A, et al. Adipose tissue dysfunction and obesity-related male hypogonadism. Int J Mol Sci. 2022;23:8194.
Article CAS PubMed PubMed Central Google Scholar
Finkelstein JS, Lee H, Burnett-Bowie S-AM, Pallais JC, Yu EW, Borges LF, et al. Gonadal steroids and body composition, strength, and sexual function in men. N. Engl J Med. 2013;369:1011–22.
Article CAS PubMed PubMed Central Google Scholar
Wake DJ, Strand M, Rask E, Westerbacka J, Livingstone DEW, Soderberg S, et al. Intra-adipose sex steroid metabolism and body fat distribution in idiopathic human obesity. Clin Endocrinol. 2007;66:440–6.
Xu X, Sun M, Ye J, Luo D, Su X, Zheng D, et al. The effect of aromatase on the reproductive function of obese males. Horm Metab Res. 2017;49:572–9.
Article CAS PubMed Google Scholar
Wang S-K, Lee M-C, Hung C-L, Chen H-H, Liao C-C, Chiu Y-L. Association between hypertriglyceridemic waist phenotype and hypogonadism in Taiwanese adult men. PLoS ONE. 2022;17:e0265629.
Article CAS PubMed PubMed Central Google Scholar
Davidson LM, Millar K, Jones C, Fatum M, Coward K. Deleterious effects of obesity upon the hormonal and molecular mechanisms controlling spermatogenesis and male fertility. Hum Fertil. 2015;18:184–93.
Bellastella G, Menafra D, Puliani G, Colao A, Savastano S, Obesity Programs of nutrition ER. How much does obesity affect the male reproductive function? Int J Obes Suppl. 2019;9:50–64.
Article PubMed PubMed Central Google Scholar
Salim S. Oxidative stress and the central nervous system. J Pharm Exp Ther. 2017;360:201–5.
Bisht S, Faiq M, Tolahunase M, Dada R. Oxidative stress and male infertility. Nat Rev Urol. 2017;14:470–85.
Comments (0)